Scientists bank Babies' cord blood in hope for future sickle cell cures
NCT ID NCT00012545
Summary
This study aimed to learn the best methods for collecting, processing, and storing umbilical cord blood from babies. The goal was to preserve the stem cells in this blood for potential future use in advanced treatments for sickle cell disease, such as stem cell transplants or gene therapy. Researchers enrolled pregnant women at risk of having a baby with sickle cell disease to donate their baby's cord blood after birth for storage and research.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SICKLE CELL DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
Conditions
Explore the condition pages connected to this study.